Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
visible-on: Access Campaign
Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug
Read More
EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver
Read More
Access to medicines: MSF applauds US’ leadership on waiving IP for COVID-19 vaccines
Read More
Access to medicines: Will history repeat itself?
Read More
COVID-19: Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic
Read More
MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public
Read More
Access to Medicines: In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic
Read More
COVID-19: Diagnostic company Cepheid charging four times more than it should for COVID-19 tests
Read More
COVID-19 vaccine: 6 recommendations for equitable access
Read More
COVID-19: Unregulated market for personal protective equipment puts lives at risk
Read More